PTCB PTCE Dumps

To determine the total number of10 mg prednisone tabletsrequired to fill the prescription, let's break it down by daily dosing:

First 2 days→ 20 mgtwice daily(b.i.d) =40 mg per day

Total for 2 days:40 mg × 2 =80 mg

Next 2 days→ 20 mgonce daily=20 mg per day

Total for 2 days:20 mg × 2 =40 mg

Next 2 days→ 10 mgonce daily=10 mg per day

Total for 2 days:10 mg × 2 =20 mg

Final 2 days→ 5 mgonce daily=5 mg per day

Total for 2 days:5 mg × 2 =10 mg

Days 1–4:(20 mg doses) → Each 20 mg dose requirestwo 10 mg tablets

Total for these 4 days:(20 mg × 4 days) = 80 mg

Tablets required:80 mg ÷ 10 mg =8 tablets

Days 5–6:(10 mg doses) → Each day requiresone 10 mg tablet

Total for these 2 days:10 mg × 2 =20 mg

Tablets required:20 mg ÷ 10 mg =2 tablets

Days 7–8:(5 mg doses) → Each day requireshalf of a 10 mg tablet

Total for these 2 days:5 mg × 2 =10 mg

Tablets required:1 full tablet (split into halves for two doses)

Step 1: Understanding the Prescription DirectionsStep 2: Determining the Number of 10 mg Tablets NeededFinal Calculation:8 tablets (Days 1-4) + 2 tablets (Days 5-6) + 1 tablet (Days 7-8) = 15 tablets

PTCB PTCE Exam Content Outline– Covers dosage calculations, unit conversions, and prescription interpretation.

Basic Pharmacy Math Principles– Ensuring proper medication dispensing based on prescription instructions.

Pharmacy Practice Guidelines– Proper dispensing techniques for titration therapy, such as steroid tapering.

Key References:

Emulsionsaremixtures of two immiscible liquids (e.g., oil and water) stabilized by an emulsifying agent.

When an emulsion breaks (phase separation occurs), the oil and water separate permanently, rendering the medication unusable.

Why Other Options Are Incorrect:

A. Tinctures?❌Alcohol-based solutions with dissolved drug, no phase separation occurs.

B. Solutions?❌Homogeneous mixtures that do NOT separate.

C. Suspensions?❌May settle over time but can be re-mixed by shaking.

????Reference:USP <795> Compounded Dosage Forms, PTCE Compounding Guidelines.

Varenicline is a partial agonist at α4β2 nicotinic acetylcholine receptors indicated for smoking cessation to aid in quitting tobacco use. It is not indicated for ulcerative colitis, seasonal affective disorder, or sleepwalking.

References (Pharmacy Technician documents/Study Guides):

• FDA-approved indications for varenicline; pharmacology overview in technician certification guides.

• PTCB/ExCPT drug indications: smoking cessation therapies (varenicline, bupropion SR, NRTs).

• Standard pharmacy references on CNS agents used for tobacco cessation.